# Zentalis Pharmaceuticals, Inc.: Form 8-K, filed Mar 17, 2025

- Company: [Zentalis Pharmaceuticals, Inc.](/companies/zntl.md) (CIK 1725160)
- Form: 8-K
- Filed: 2025-03-17
- Accepted by EDGAR: Mar 17, 2025, 06:13 ET
- Period: 2025-03-15
- Accession: 0001628280-25-012899
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1725160/000162828025012899/zntl-20250315.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1725160/000162828025012899/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1725160/000162828025012899/zntl-20250315.htm

Filed Mar 17, 2025.
Source: SEC EDGAR, the filing index for accession 0001628280-25-012899. Last ingested by Listed: Oct 27, 2026, 17:29 ET. No prices; not investment advice.